medigraphic.com
ISSN 1561-3046 (Electronic)

2020, Number 3

<< Back Next >>

Rev Cub Med Mil 2020; 49 (3)

Impact of vascular risk factors on the frequency of chronic renal failure

González TR, Acosta GFA, Trimiño GL

Language: Spanish
References: 21
Page:
PDF size: 346.63 Kb.


ABSTRACT

Introduction: Chronic renal insufficiency is related to multiple vascular risk factors. The prevalence of these entities has increased in Cuba in recent decades, associated with population aging.
Objective: To identify the relationship between chronic renal failure, diagnosed according to glomerular filtration stages, with vascular risk factors (obesity, high blood pressure, diabetes mellitus, hyperlipoproteinemia, smoking) and established cardiovascular disease.
Methods: A descriptive, cross-sectional study was carried out in 2913 patients. General, anthropometric data, vascular risk factors, and hemochemistry were collected. Carriers of chronic renal insufficiency were considered those with glomerular filtration rate lower than 60 mL / min / 1.73 m2. The relationship between chronic renal insufficiency and vascular risk factors was identified using the Odds Ratio. The mean values of the hemochemical variables were compared with one-way ANOVA.
Results: 10.8% of chronic renal insufficiency (15.3% in women) was found, its frequency increased with age and was associated with the selected risk factors (established cardiovascular disease: OR 3,58; hyperlipoproteinemia: OR 2,96; hypertension: OR 2,95; diabetes mellitus: OR 2,70 and obesity: OR 1,33). The frequency of chronic renal insufficiency as well as blood glucose, cholesterol, triglyceride and HbA1c levels increased with the sum of risk factors.
Conclusions: chronic renal insufficiency was very frequent in this series. It prevailed in the female sex and in the most advanced age groups. A significant relationship with the selected risk factors was found, which was higher in patients with established cardiovascular disease.


REFERENCES

  1. World Health Organization. Noncommunicable diseases country profiles 2018. 2018[acceso: 30/07/2019]. Disponible en: http://www.who.int/nmh/publications/ncd-profiles-2018/en/

  2. Miguel Soca PE, Sarmiento Teruel Y, Mariño Soler AL, Llorente Columbié Y, Rodríguez Graña T, Peña González M. Prevalencia de enfermedades crónicas no transmisibles y factores de riesgo en adultos mayores de Holguín. Revista Finlay 2017[acceso: 30/07/2019]; 7(3):155-67. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2221-24342017000300002

  3. Benet Rodríguez M, Morejón Giraldoni A, Espinosa Brito A, Landrove Rodríguez O, Peraza Alejo D, Orduñez García P. Factores de Riesgo para Enfermedades Crónicas en Cienfuegos, Cuba 2010. Resultados preliminares de CARMEN II. Medisur. 2010 [acceso: 30/07/2019]; 8(2):117-20. Disponible en: https://www.medisur.sld.cu/index.php/medisur/article/view/1166

  4. Kidney disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements. 2013[acceso: 30/07/2019]; 3(1):1-150. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84896705051&doi=10.1038%2fkisup.2012.73&partnerID=40&md5=819e-1361bc275b149547df226e5732c5

  5. Herrera R, Almaguer M, Chipi J, Toirac X, Martinez O, Castellanos O, et al. Detection of markers of cardiovascular and renal risk in Cuba: Isle of Youth Study (ISYS). Nephron Clin Pract. 2011[acceso: 30/07/2019]; 117(4):c353-62. Disponible en: https://www.karger.com/Article/Pdf/321505

  6. Silva Junior GBd, Oliveira JGRd, Oliveira MRBd, Vieira LJEdS, Dias ER. Global costs attributed to chronic kidney disease: a systematic review. Revista da Associação Médica Brasileira. 2018[acceso: 30/07/2019]; 64:1108-16. Disponible en: https://www.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302018001201108&nrm=iso

  7. González Tabares R, O'Relly Noda D, Guirola Fuentes J, Pérez Barly L, Acosta González FA, Navarro de Armas OL. Disglucemia y aterosclerosis en población laboralmente activa. Revista Cubana de Medicina Militar. 2016[acceso: 30/07/2019]; 45:277-90. Disponible en: https://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S0138-65572016000300003&nrm=iso

  8. González Tabares R, Acosta González FA, Trimiño Galindo L, Guardarrama Linares L. Factores de riesgo metabólico y enfermedad cardiovascular asociados a obesidad en una población laboralmente activa. Rev cuba med gen. 2020 [acceso: 10/02/2020];36(1):[aprox. 14 p.]. Disponible en: https://revmgi.sld.cu/index.php/mgi/article/view/1040

  9. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976 [acceso: 30/07/2019];16(1):31-41. Disponible en: https://www.researchgate.net/profile/Donald_Cockcroft/publication/2-1910265_Cockcroft_DW_Gault_-MHPrediction_of_creatine_clearance_from_serum_creatinine_Nephron_16_31-41/links/5989e55aaca272435851670a/Cockcroft-DW-Gault-MHPrediction-of-creatine-clearance-from-serum-creatinine-Nephron-16-31-41.pdf

  10. Gorostidi M, Sánchez-Martínez M, Ruilope LM, Graciani A, de la Cruz JJ, Santamaría R, et al. Prevalencia de enfermedad renal crónica en España: impacto de la acumulación de factores de riesgo cardiovascular. Nefrología. 2018 [acceso: 30/07/2019]; 38(6):606-15. Disponible en: https://www.sciencedirect.com/science/article/pii/S0211699518300754

  11. Khan YH, Mallhi TH, Sarriff A, Khan AH, Tanveer N. Prevalence of chronic kidney disease in Asia: A systematic review of population-based studies. Journal of the College of Physicians and Surgeons Pakistan. 2018 [acceso: 30/07/2019]; 28(12):960-6. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85057616468&doi=10.29271%2fjcpsp.2018.12.960&partnerID=40&md-5=ae97e8f8bb9273f2448f500ba8c77f28

  12. Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney International. 2018 [acceso: 30/07/2019]; 94(3):567-81. Disponible en: https://www.sciencedirect.com/science/article/pii/S0085253818303181

  13. Bello AK, Ronksley PE, Tangri N, Kurzawa J, Osman MA, Singer A, et al. Prevalence and Demographics of CKD in Canadian Primary Care Practices: A Cross-sectional Study. Kidney International Reports. 2019[acceso: 30/07/2019]; 4(4):561-70. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85062730536&doi=10.1016%2fj.ekir.2019.01.005&partnerID=40&md5=0-494eb0a64179f87d2cda41fb92780b3

  14. Bonet Gorbea M, Varona Pérez P, Chang la Rosa M, García Rocha RG, Suárez Medina R, Arcia Montes de Oca N, et al. III Encuesta Nacional de Factores de Riesgo y Actividades Preventivas de Enfermedades no Transmisibles. Cuba 2010-2011. La Habana: ECIMED; 2014[acceso: 30/07/2019]. Disponible en: https://www.researchgate.net/profile/Maria_Diaz27/publication/32-5370535_III_Encuesta_Nacional_de_Factores-_de_Riesgo_y_actividades_preventivas_de_ENT_Cuba_2010-2011/links/5b6dd390299bf14c6d98c228/III-Encuesta-Nacional-de-Factores-de-Riesgo-y-actividades-preventivas-de-ENT-Cuba-2010-2011.pdf

  15. Gimeno JA, Lou LM, Molinero E, Campos B, Boned B, Sánchez Vañó R. Concordancia entre las fórmulas de Cockcroft Gault y del estudio MDRD para estimar la tasa de filtación glomerular en pacientes con diabetes tipo 2. Nefrología. 2006[acceso: 30/07/2019]; 26(5):615-8. Disponible en: https://www.revistanefrologia.com/es-concordancia-entre-las-formulas-cockcroft-articulo-X021169950602027XER

  16. Dalmau Llorca MR, Boira Costa M, López Pablo C, Pepió Vilaubí JM, Aguilar Martin C, Forcadell Drago E. Diferencias entre MDRD-4 y CG en la prevalencia de la insuficiencia renal y sus variables asociadas en pacientes diabéticos tipo2. Atención Primaria. 2016 [acceso: 30/07/2019]; 48(9):596-603. Disponible en: https://www.sciencedirect.com/science/article/pii/S0212656716300415

  17. Castellanos Castillo Y, Fong Estrada JA, Vázquez Trigo JM, Fong J. Marcadores de daño renal en pacientes con factores de riesgo de enfermedad renal crónica. MEDISAN. 2018[acceso: 30/07/2019]; 22:142-8. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192018000200004&nrm=iso

  18. Rowe JW, Andres R , Tobin JD, Norris AH, Shock NW. Age-adjusted standards for creatinine clearance. Ann Intern Med. 1976 [acceso: 30/07/2019];84(5):567-9. Disponible en: https://annals.org/aim/article-abstract/690272/age-adjusted-standards-creatinine-clearance

  19. Gámez Jiménez AM, Montell Hernández OA, Ruano Quintero V, Alfonso de León JA, Hay de la Puente Zoto M. Enfermedad renal crónica en el adulto mayor. Rev Méd Electrón. 2013[acceso: 30/07/2019]; 35(4). [aprox. 12 pant.] Disponible en: https://www.revmatanzas.sld.cu/revista%20medica/ano%202013/vo-l4%202013/tema01.htm

  20. American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019[acceso: 30/07/2019]; 42(Supplement 1):S124-S38 pp. Disponible en: https://care.diabetesjournals.org/content/diacare/42/Suppleme-nt_1/S124.full.pdf

  21. Pérez-Oliva Díaz JF, Almaguer López M, Herrera Valdés R, Martínez Machín M, Martínez Morales M. Registro de la Enfermedad Renal Diabética en la Atención Primaria de Salud. Cuba, 2015. Rev haban Cien Méd. 2017 [acceso: 30/07/2019]; 16:666-79. Disponible en: https://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2017000400018&nrm=iso




2020     |     www.medigraphic.com